股票代码：******

Shenzhen Gaoxin Investment and Huayu Hengtai visit the institute for research

Published:

2022-01-14

Promote a win-win development cycle Integrate into the Greater Bay Area bridgehead

From November 26 to 30, 2021, a delegation of 7 people from Shenzhen High-tech Investment Group Co., Ltd. Talent Equity Investment Fund Management Co., Ltd. and 2 people from Shenzhen Huayu Hengtai Commercial Factoring Co., Ltd., accompanied by the company's Vice Chairman Jing Yue, specially visited the company for investment research. Company investors and board representatives accompanied the research.

This research aims to gain an in-depth understanding of the company's independent innovation, production operations, and IPO listing integration, comprehensively grasping our company's progress in promoting economic development and IPO planning operations. After visiting the company's marketing center, quality research facilities, production workshops, and the new Xilin bottle technical renovation workshop, the research team fully affirmed the achievements and efforts of our company, learned in detail about the company's production and sales in recent years, and provided relevant opinions and suggestions to better promote the company's rapid development.

The research team had extensive and in-depth exchanges and communications with the company leaders regarding the company's operations. They attended the monthly meetings of the company's four special working groups throughout, listened to reports from the headquarters and subsidiaries' special work leaders on last month's progress and activities, and gained a detailed understanding of the company's work plans and goals for the next month.

At the meeting, the company's Vice Chairman emphasized the need to further accelerate the construction of the technological innovation system, focusing on comprehensively enhancing industrial innovation, addressing weaknesses, strengthening weak points, concentrating on "industrial essentials and technological calls," improving production technology levels, strictly supervising product quality, and striving to make project products high-quality. High standards will be set for next year's key work, using practical results to test product effectiveness, gathering the powerful force of joint efforts, and creating "high-quality medicines that reassure patients and satisfy the public." The leader of the High-tech Investment research team affirmed the achievements of the company's four special working groups and expressed high hopes for the company's development. He pointed out that the company has advantages in raw material supply, industrial layout, and research advantages in the biopharmaceutical field, with huge development potential. He hopes to maintain and promote good ideas, methods, and results in management, research, technical renovation, and material support to better promote the company's development. The leader of the Huayu Hengtai research team said in his speech that developing the company into a bridgehead integrated into the Greater Bay Area is a major opportunity to promote the company's high-quality leapfrog development, an important part of building the Jiangxi Biological Demonstration Zone, and a vivid practice to promote high-quality development in the old revolutionary base areas. Jiangxi Biology is timely and in line with the trend.

After the research, Chairman Jing Yue expressed heartfelt thanks to the research team for their long-term care and support for our company. Based on cooperation and win-win principles, the company strives to innovate on solid high-tech foundations and build platforms. It will continue to strengthen cooperation with "major institutes and domestic and international prestigious universities, select talents in an unconventional way, and establish a first-class scientific research and production management team; develop on the existing foundation and reach a higher level. Strengthen core leadership, deeply cultivate and expand specialized focused fields, and strive to break through a batch of industrial innovations and technical bottlenecks. Seek depth in improving connotation and work hard. From both the raw material supply side and market demand ends, increase product upgrades and replacements, improve specialization capabilities, focus on building core competitive advantages, and promote the company's rapid development. It is hoped that through joint efforts, daring to explore new paths, mutual assistance, and win-win cooperation, the company will continuously innovate and deeply integrate, strive to be the industry's leading pioneer, and push the company to new heights.

Mayor Luo Wenjiang and his delegation visited our company to conduct research and provide guidance

Expand and strengthen the biopharmaceutical and health industry, consolidate and expand the achievements of poverty alleviation, Luo Wenjiang conducts research in Jinggangshan Economic Development Zone and Qingyuan District

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales: